Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
mRNA | BRD9876 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
mRNA | B02 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.8 |
mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.8 |
mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.8 |
mRNA | UNC0638 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |